Celerion is a clinical research organization (CRO) specializing in early-phase (Phase I) clinical trials and translational medicine. The company provides clinical research solutions, innovative technologies, and therapeutic and specialty expertise to help get drugs to market faster. Celerion offers specialized procedures including echocardiograms, CSF collection, cognitive testing, imaging, and molecular/cellular capabilities including flow cytometry and ELISpot testing.
Phase I clinical trials, translational medicine, pharmacokinetics, bioanalytical services, flow cytometry, ELISpot, cardiac safety studies
6 sites worldwide
Involvement in 3 clinical trials
No reviews available yet.
No documents available.